New study aims to perfect antibiotic dosing for kids with cystic fibrosis
NCT ID NCT03771313
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study involved 8 children and teens with cystic fibrosis who had a history of MRSA infection and were being treated with the antibiotic ceftaroline. Researchers measured drug levels in the blood at different times to see how well the body processes the medicine. The goal was to develop personalized dosing guidelines that improve treatment and reduce side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 42229, United States
Conditions
Explore the condition pages connected to this study.